22. October 2020

Halle (Saale), 21.10.2020 – Although periodontitis is a widespread infectious disease affecting around 30% of the global population, there are currently no effective treatments available — yet. PerioTrap Pharmaceuticals, a Fraunhofer IZI spin-off, has developed a novel treatment strategy that...

26. June 2019
18. June 2019

bmp Ventures invests seven-figures in Augmented Reality
Startup 3DQR with IBG funds and a Business Angel

17. May 2019

close2real GmbH launches training platform and closes financing round for development of platform for case-based learning with simulations and training in medicine

29. April 2019


Sustainable growth financing: The investment company Marondo Capital joins the Freiburg-based e-commerce platform provider OXID eSales.

15. April 2019

Auto Digitalisierungsspezialist erhält zweistelligen Millionenbetrag für globale Marktexpansion

15. April 2019

Probiodrug raises EUR 8.2 million in successful private placement of new shares

  • Consortium of strategic investors led by Dr. Claus Christiansen founder and chairman of the board of Nordic Bioscience, Denmark, invests EUR 6.2 million
  • Proceeds used to initiate the...
15. April 2019

Probiodrug wirbt EUR 8,2 Mio mittels erfolgreicher Privatplatzierung von neuen Aktien ein

  • Ein von Claus Christiansen, Gründer und Chairman von Nordic Bioscience, geführtes Konsortium strategischer Investoren partizipiert mit EUR 6,2 Mio.
  • Die Einnahmen werden zur Einleitung...
21. March 2019

Probiodrug AG to Publish its Full Year 2018 Results on March 28, 2019

20. March 2019

Probiodrug and Alzheimer's Disease Cooperative Study (ADCS) Receive 15 Million USD National Institutes of Health (NIH) Grant for U.S. Phase 2b Core Program for PQ912

Study to Evaluate Safety and Efficacy of Drug Seeking to Treat Those with Mild Cognitive Impairment or Mild Dementia...